Author: Tim Hirst

Adelaide, Australia, 18 November 2019 – GPN Vaccines is pleased to announce Dr Lauren Giorgio has been appointed as the Company’s Chief Operating Officer. Lauren brings valuable experience in intellectual property management, business development, stakeholder engagement, commercialisation and operations in the life sciences sector, encompassing the...

Adelaide, Australia, 21 May 2019 – Gamma-PN boosts the immune systems’ response to flu vaccination GPN Vaccines’ serotype-independent pneumococcal vaccine, Gamma-PNTM has been found to boost the immune systems’ response to flu vaccination when it is given at the same time as an influenza vaccine. Gamma-PNTM’s ability to do...

Protecting children and adults from the world’s foremost bacterial pathogen